Qomel says subsidiary gets GMP certification

Logo of Qomel Co. 

The certification covers the packaging stage of human pharmaceutical products, following the factory’s fulfillment of SFDA’s requirements and compliance with locally approved standards, Qomel said in a Tadawul filing.

Trial operations at the facility have begun, marking a step toward the transition to commercial production in line with approved plans.

Qomel said it expects the positive financial impact of the certification to start in the first half of 2026, following the completion of commercial operations and the stabilization of production capacity.

The milestone aligns with its strategy to strengthen manufacturing capabilities, localize pharmaceutical production, and support domestic drug supply chains, in line with Saudi Vision 2030, the statement added.